Moreover, patients in HCG11 high/miR‐496 low group had the highest overall survival rate, while patients in HCG11 low/miR‐496 high group had the lowest overall survival, indicating HCG11 and miR‐496 potentially synergistically affected the overall survival of glioma patients. The gene discussed is HCG11; the disease is central nervous system cancer.